GB1053837A - - Google Patents
Info
- Publication number
- GB1053837A GB1053837A GB1053837DA GB1053837A GB 1053837 A GB1053837 A GB 1053837A GB 1053837D A GB1053837D A GB 1053837DA GB 1053837 A GB1053837 A GB 1053837A
- Authority
- GB
- United Kingdom
- Prior art keywords
- nonapeptide
- cysteinyl
- condensing
- benzyl
- acid addition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- CAXCRXDCRBCENL-FQEVSTJZSA-N (2s)-3-hydroxy-2-(tritylazaniumyl)propanoate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(N[C@@H](CO)C(O)=O)C1=CC=CC=C1 CAXCRXDCRBCENL-FQEVSTJZSA-N 0.000 abstract 1
- KPYXMALABCDPGN-HYOZMBHHSA-N (4s)-5-[[(2s)-6-amino-1-[[(2s,3s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2r)-1-[[2-[[2-[[(1s)-3-amino-1-carboxy-3-oxopropyl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]a Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN)CC1=CC=C(O)C=C1 KPYXMALABCDPGN-HYOZMBHHSA-N 0.000 abstract 1
- 125000000010 L-asparaginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(=O)N([H])[H] 0.000 abstract 1
- 230000002686 anti-diuretic effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/15—Oxytocin or vasopressin; related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH551463A CH421130A (de) | 1963-05-02 | 1963-05-02 | Verfahren zur Herstellung eines bisher unbekannten Polypeptids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1053837A true GB1053837A (cg-RX-API-DMAC10.html) |
Family
ID=4294894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1053837D Active GB1053837A (cg-RX-API-DMAC10.html) | 1963-05-02 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3299037A (cg-RX-API-DMAC10.html) |
| AT (1) | AT251208B (cg-RX-API-DMAC10.html) |
| BE (1) | BE647403A (cg-RX-API-DMAC10.html) |
| CH (1) | CH421130A (cg-RX-API-DMAC10.html) |
| ES (1) | ES299388A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR1397571A (cg-RX-API-DMAC10.html) |
| GB (1) | GB1053837A (cg-RX-API-DMAC10.html) |
| NL (1) | NL6404536A (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS563846B2 (cg-RX-API-DMAC10.html) * | 1972-10-12 | 1981-01-27 | ||
| JPS60500055A (ja) * | 1983-02-15 | 1985-01-17 | ア−マ−・ファ−マシュ−ティカル・カンパニ− | グリシン−８−カルシトニン |
| WO1984003279A1 (en) * | 1983-02-15 | 1984-08-30 | Armour Pharma | Des-asparagine-3 calcitonin |
| US4481191A (en) * | 1983-03-30 | 1984-11-06 | The Regents Of The University Of California | Method for controlling blood pressure |
| WO2017136600A1 (en) | 2016-02-04 | 2017-08-10 | ALASTIN Skincare, Inc. | Compositions and methods for invasive and non-invasive procedural skincare |
| EP3661538A4 (en) | 2017-08-03 | 2021-07-14 | Alastin Skincare, Inc. | COMPOSITIONS AND PROCEDURES FOR IMPROVING SLEEPING SKIN AND BODY CONTOUR |
| WO2020028694A1 (en) | 2018-08-02 | 2020-02-06 | ALASTIN Skincare, Inc. | Liposomal compositions and methods of use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2854443A (en) * | 1955-10-12 | 1958-09-30 | Saul & Co | Alyl-oxytocin and process for the preparation thereof |
-
0
- GB GB1053837D patent/GB1053837A/en active Active
-
1963
- 1963-05-02 CH CH551463A patent/CH421130A/de unknown
-
1964
- 1964-04-24 NL NL6404536A patent/NL6404536A/xx unknown
- 1964-04-28 US US363285A patent/US3299037A/en not_active Expired - Lifetime
- 1964-04-30 ES ES299388A patent/ES299388A1/es not_active Expired
- 1964-04-30 FR FR972969A patent/FR1397571A/fr not_active Expired
- 1964-04-30 BE BE647403A patent/BE647403A/xx unknown
- 1964-05-04 AT AT390764A patent/AT251208B/de active
Also Published As
| Publication number | Publication date |
|---|---|
| ES299388A1 (es) | 1964-12-01 |
| BE647403A (cg-RX-API-DMAC10.html) | 1964-10-30 |
| CH421130A (de) | 1966-09-30 |
| US3299037A (en) | 1967-01-17 |
| AT251208B (de) | 1966-12-27 |
| FR1397571A (fr) | 1965-04-30 |
| NL6404536A (cg-RX-API-DMAC10.html) | 1964-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3881592D1 (de) | Lhrh antagonisten, deren herstellung und entsprechende pharmazeutische zubereitungen. | |
| GB1155919A (en) | A Novel Antidiuretically Active Polypeptide, Salts Thereof, And A Process Of Manufacturing Same | |
| GB1230472A (cg-RX-API-DMAC10.html) | ||
| DE69411342D1 (de) | Polypeptid bombesin antagonisten | |
| ES2133295T3 (es) | Peptidos ciclicos y su uso. | |
| GB1281383A (en) | Sulphonated peptides and their production | |
| ATE14886T1 (de) | Gnrh-antagonisten. | |
| GB1109086A (en) | Polypeptides | |
| GB1294771A (en) | Thyrocalcitonin derivative | |
| GB1526367A (en) | Polypeptide | |
| GB1140873A (en) | Polypeptides | |
| GB1374908A (en) | Decapeptide | |
| GB1051686A (cg-RX-API-DMAC10.html) | ||
| GB1278681A (en) | Peptides | |
| GB1071349A (en) | Adrenocorticotropically active peptides and process for preparing them | |
| US3318864A (en) | Alanine4-oxytocin | |
| GB1173437A (en) | Pentacosapeptides | |
| EP0307662A3 (en) | Enkephalin analogs | |
| Liébecq | Abbreviated designation of amino acid derivatives and peptides | |
| ES361305A1 (es) | Un metodo para la inhibicion de la enzima doparmina-3-hi- droxilasa. | |
| GB1125349A (en) | Soluble salts of ellagic acid | |
| GB1190077A (en) | Peptides and Process for Preparing them | |
| GB1210551A (en) | New peptides having an acth-activity and process for their manufacture | |
| GB1273873A (en) | Corticotropically highly active octadecapeptides | |
| Ramakrishnan et al. | Nuclear overhauser effects as probes of peptide structure. A diagnostic for left-handed helical conformations |